Mucosal regeneration therapy by autologous intestinal stem cell transplantation to inflammatory bowel disease patients. - Intestinal stem cell transplantation to inflammatory bowel disease patients.

Tokyo Medical and Dental University0 个研究点目标入组 8 人开始时间: 2018年4月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Past history of colectomy. (2)Planning or awaiting colectomy. (3)Satisfies contraindication criteria for colonoscopy. (4)Failure to confirm the presence of un-inflamed region by colonoscopy performed within 4-weeks from study entry. (5)Presence of gastrointestinal dysplasia. (6)Complication of colitis other than ulcerative colitis. (7)Presence of active infection. (8)Poor general condition. (9)Past history or suspected presence of malignancy within 5 years from study entry. (10)Having difficulty in making self-decision due to diseases such as dementia. (11)Pregnant or lactating women, including suspected pregnancy or those anticipating pregnancy. (12)Allergy against Neoveil or Beriplast. (13)Allergy against aprotinin, thrombin, fibrinogen, or polyglycolic acid. (14)Allergy against gentamycin or streptomycin. (15)Under treatment with antithrombotic drugs. (16) Under treatment either with hemocoagulase, epsilon aminocaproic acid, tranexamic acid, or aprotinin. (17) Recommended to be excluded by the study director or other study members.

发起方